- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by ArmaGen, Inc
Total 36849 results
-
AmgenCompletedBone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast Cancer | Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma
-
AmgenCompleted
-
AmgenCompletedHealthy Volunteers
-
AmgenCompleted
-
AmgenCompletedNeoplasm Metastasis | Lung Cancer | Non-small Cell Lung Cancer
-
AmgenCompletedBreast Cancer | Non-Hodgkin's Lymphoma | Ovarian Cancer | Lung Cancer | Neutropenia
-
AmgenCompletedSarcoma | Neutropenia
-
AmgenCompleted
-
AmgenCompletedEnd Stage Renal Disease
-
AmgenCompletedChronic Kidney Disease | Kidney Disease
-
AmgenCompletedLymphoma | Breast Neoplasms | Lung Neoplasms | Multiple Myeloma | Chronic Lymphocytic Leukemia
-
AmgenCompleted
-
AmgenCompleted
-
AmgenCompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Kidney Disease
-
AmgenCompleted
-
AmgenTerminatedChronic Kidney Disease
-
AmgenCompleted
-
AmgenCompleted
-
AmgenCompletedHyperparathyroidism | Secondary Hyperparathyroidism | Kidney Tansplant
-
AmgenCompletedAnemia | Non-Small Cell Lung Cancer
-
AmgenCompleted
-
AmgenCompletedNeoplasm Metastasis | Non-Small Cell Lung Cancer | Lung Cancer
-
AryoGen Pharmed Co.CompletedSevere Hemophilia AIran, Islamic Republic of
-
AryoGen Pharmed Co.Completed
-
AryoGen Pharmed Co.CompletedHemophilia A With Inhibitor | Hemophilia B With InhibitorIran, Islamic Republic of
-
AryoGen Pharmed Co.CompletedHemophilia A or B With InhibitorIran, Islamic Republic of, Turkey
-
AryoGen Pharmed Co.CompletedRheumatoid Arthritis | Psoriatic Arthritis | Ankylosing SpondylitisIran, Islamic Republic of
-
AryoGen Pharmed Co.Unknown
-
AmgenRecruitingAtopic DermatitisUnited States
-
AmgenRecruitingPostmenopausal OsteoporosisIndia
-
AmgenRecruitingMelanomaItaly, Spain, Czechia, Estonia, Bosnia and Herzegovina, Portugal, Romania, Georgia, Lithuania, Malaysia, United States, France, Canada, Thailand, Croatia, Mexico, Serbia
-
AmgenRecruiting
-
AmgenRecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, United States, Israel, Italy, Spain, Australia, Germany, United Kingdom, Austria, France, Japan, Switzerland, Taiwan, Belgium, Poland, China, Thailand, Canada, Czechia, Singapore, Hungary, Argentina, Brazil, Portugal, Roman... and more
-
AmgenRecruitingUlcerative ColitisUnited States, Taiwan, Switzerland, Germany, Spain, Turkey, Greece, Japan, Denmark, Korea, Republic of, Austria, Italy, Netherlands, Poland, Romania, Belgium, Argentina, Bulgaria, Czechia, Finland, Hungary, Mexico, Latvia, France, Canada, Slovaki...
-
AmgenRecruitingGiant Cell Tumor of BoneTaiwan, China
-
AmgenRecruitingBehçet DiseaseSpain, United Kingdom, Turkey, France, Greece, Italy, Israel, Switzerland
-
AmgenRecruitingB Cell Precursor Acute Lymphoblastic LeukemiaJapan, Australia, Spain, United States, Italy, Germany, France, Turkey, Canada, Netherlands, Austria
-
AmgenRecruitingB-precursor Acute Lymphoblastic LeukemiaUnited States
-
AmgenRecruitingAdvanced Solid Tumors | Kirsten Rat Sarcoma (KRAS) pG12C MutationUnited States, Italy, Taiwan, Spain, United Kingdom, Australia, Austria, Germany, Belgium, Japan, Netherlands, Korea, Republic of, Canada
-
AmgenRecruitingChemotherapy-induced ThrombocytopeniaUnited States, Spain, Turkey, Argentina, Greece, Austria, Brazil, Bulgaria, Chile, Colombia, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Ukraine, Hungary
-
AmgenRecruitingMelanoma | Herpetic InfectionUnited Kingdom, Austria, United States, Israel, Switzerland
-
AmgenAvailableSmall Cell Lung CancerUnited States, Brazil
-
AmgenCompletedOsteogenesis ImperfectaSpain, United States, Turkey, Austria, Germany, Greece, Hungary, Italy
-
AmgenActive, not recruitingAtherosclerotic Cardiovascular DiseaseUnited States, Belgium, Spain, China, Korea, Republic of, Australia, Netherlands, Austria, Czechia, Taiwan, Italy, Portugal, Greece, Hong Kong, Hungary, United Kingdom, France, Bulgaria, Germany, Finland, Japan, Sweden, Canada, Denmark, Icelan... and more